Partner David Rosen was quoted in a Modern Healthcare article, “Stakeholders anxious about FDA losing momentum after Gottlieb exits,” about the legacy of Food and Drug Administration Commissioner Dr. Scott Gottlieb, who announced his resignation last week.
Rosen said Gottlieb did a great job improving the generic-drug review and approval process, but that more needs to be done to address branded drugs that have no competition. “I still think the barrier to entry for generics is pretty high,” he said, citing the often insurmountable costs. “Also, the whole issue about patent certification is still subject to a fair amount of debate and clarification.”
Rosen said Gottlieb did a great job improving the generic-drug review and approval process, but that more needs to be done to address branded drugs that have no competition. “I still think the barrier to entry for generics is pretty high,” he said, citing the often insurmountable costs. “Also, the whole issue about patent certification is still subject to a fair amount of debate and clarification.”
People
Related News
23 April 2024
In the News
David Sanders Discusses Lessons Learned from General Counsel Leadership Program
Foley & Lardner LLP partner David Sanders recently joined a panel discussion with members of The Vanguard Network’s General Counsels Advisory Group to discuss the evolving role of the general counsel.
23 April 2024
In the News
Claire Marblestone Discusses HHS Final Rule on Protected Health Information Disclosure
Foley & Lardner LLP Claire Marblestone assessed the U.S. Department of Health and Human Services’ final rule that bars providers, health plans, and other entities covered by the Health Insurance Portability and Accountability Act from disclosing protected health information in a Healthcare Dive article.
22 April 2024
In the News
Scott Ellis Comments on Big Law Recruiting Ramp Up – “Right out of the box, you’re looking at them as new hires”
Foley & Lardner LLP partner Scott Ellis offers insight on the rise of early recruitment by major law firms and its impact on law students in the Bloomberg Law article, “Big Law Skips Ahead of On-Campus Recruiting in Talent Race."